GlassScriptPhysician profile
Ryan Gerhartz
NPI 1669771721
$2,030.02
in general payments reported to CMS, 2019-2025
12 companies · $115 in 2025
The $115 reported for 2025 was less than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $19.93 · 2023: $1,521 · 2024: $374 · 2025: $115.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,096 · Food and Beverage: $914.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,096.19 |
| Food and Beverage | $913.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,495.26 | 2023-2024 | Axonics |
| Abbvie INC. | $189.74 | 2022-2025 | |
| Astellas Pharma US INC | $148.93 | 2023-2024 | Veozah |
| Daiichi Sankyo INC. | $45.75 | 2024 | Injectafer |
| Exeltis, USA INC. | $27.95 | 2023-2025 | Slynd |
| Smith+Nephew, INC. | $22.68 | 2025 | Pico 14 |
| Sumitomo Pharma America, INC. | $21.28 | 2023 | Myfembree |
| Pfizer INC. | $17.80 | 2024 | |
| Pharmacosmos Therapeutics INC. | $16.48 | 2025 | Monoferric |
| Merck Sharp & Dohme LLC | $16.41 | 2023 | Gardasil 9 |
| Organon LLC | $14.15 | 2025 | Nexplanon |
| Exact Sciences Corporation | $13.59 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Gerhartz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.